GlassScriptPhysician profile
Iyad Syoufi
NPI 1558315994
$11,249.60
in general payments reported to CMS, 2019-2025
53 companies · $1,606 in 2025
The $1,606 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,183 · 2020: $593 · 2021: $950 · 2022: $1,407 · 2023: $1,912 · 2024: $2,599 · 2025: $1,606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,117.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,695.70 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,151.00 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Corcept Therapeutics | $865.45 | 2019-2025 | Korlym |
| Abbott Laboratories | $793.82 | 2019-2025 | Freestyle Libre 3 |
| Amgen INC. | $689.58 | 2019-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $622.09 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $569.36 | 2019-2022 | |
| Abbvie INC. | $512.76 | 2019-2025 | Synthroid |
| Medtronic, INC. | $449.64 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Radius Health, INC. | $366.81 | 2019-2025 | Tymlos |
| Dexcom, INC. | $304.37 | 2020-2025 | Dexcom G6 Transmitter |
| Medtronic Minimed, INC. | $290.44 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.21 | 2019-2024 | Jardiance |
| Mannkind Corporation | $202.63 | 2019-2025 | Afrezza |
| Amneal Pharmaceuticals LLC | $188.17 | 2019-2025 | Unithroid |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $187.89 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Alexion Pharmaceuticals, INC. | $166.41 | 2021-2025 | Strensiq |
| Insulet Corporation | $162.48 | 2019-2024 | Omnipod |
| Xeris Pharmaceuticals, INC. | $138.69 | 2020-2024 | Recorlev, Gvoke Hypopen |
| Averitas Pharma INC. | $130.71 | 2024 | Qutenza |
| Recordati_rare_diseases_inc. | $127.12 | 2023-2025 | Isturisa, Signifor Lar |
| Horizon Therapeutics Plc | $104.97 | 2020-2023 | Tepezza |
| Sequel Med Tech, LLC | $102.01 | 2025 | Twiist |
| Boston Scientific Corporation | $100.51 | 2019 | |
| Vivus LLC | $78.85 | 2019-2024 | Qsymia |
| Ascendis Pharma Endocrinology INC | $75.75 | 2023-2025 | Yorvipath |
| Bayer Healthcare Pharmaceuticals INC. | $74.49 | 2021-2024 | |
| Ultragenyx Pharmaceutical INC. | $72.09 | 2019-2023 | |
| Shire North American Group INC | $67.70 | 2019 | |
| Intuity Medical INC | $62.09 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Antares Pharma, INC. | $56.64 | 2019-2022 | |
| Tandem Diabetes Care, INC. | $51.25 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Cequr Corporation | $47.35 | 2024 | Cequr Simplicity |
| Currax Pharmaceuticals LLC | $46.21 | 2022-2025 | Contrave, Nexletol, Nexlizet |
| Lifescan, INC. | $45.25 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.72 | 2022-2023 | |
| Alvogen INC | $40.41 | 2024-2025 | Teriparatide |
| Verity Pharmaceuticals INC. | $37.17 | 2024 | Tlando |
| Amphastar Pharmaceuticals, INC. | $35.82 | 2024 | |
| Tolmar, INC. | $33.30 | 2024-2025 | Jatenzo |
| Becton, Dickinson and Company | $28.92 | 2019 | |
| Chiesi USA, INC. | $27.60 | 2024 | Mycapssa |
| Inspire Medical Systems, INC. | $25.10 | 2025 | Inspire |
| Renalytix Ai, INC. | $22.14 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Zealand Pharma US, INC. | $20.87 | 2021 | |
| Ibsa Pharma INC. | $20.09 | 2019 | |
| Globus Medical, INC. | $18.87 | 2025 | Senza |
| Companion Medical, INC. | $16.71 | 2019 | |
| Ascensia Diabetes Care US INC. | $16.67 | 2024 | |
| Janssen Pharmaceuticals, INC | $14.93 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.89 | 2021 | |
| Merck Sharp & Dohme LLC | $11.00 | 2019 | |
| Echosens North America, INC. | $8.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iyad Syoufi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.